BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15292278)

  • 1. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
    Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
    J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
    Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct NFAT family proteins are involved in the nuclear NFAT-DNA binding complexes from human thymocyte subsets.
    Amasaki Y; Masuda ES; Imamura R; Arai K; Arai N
    J Immunol; 1998 Mar; 160(5):2324-33. PubMed ID: 9498773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.
    Lipskaia L; Pourci ML; Deloménie C; Combettes L; Goudounèche D; Paul JL; Capiod T; Lompré AM
    Circ Res; 2003 May; 92(10):1115-22. PubMed ID: 12730091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT expression in human osteoclasts.
    Day CJ; Kim MS; Lopez CM; Nicholson GC; Morrison NA
    J Cell Biochem; 2005 May; 95(1):17-23. PubMed ID: 15759284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steel factor sustains SCL expression and the survival of purified CD34+ bone marrow cells in the absence of detectable cell differentiation.
    Caceres-Cortes JR; Krosl G; Tessier N; Hugo P; Hoang T
    Stem Cells; 2001; 19(1):59-70. PubMed ID: 11209091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells.
    Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ
    J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
    Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
    Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes.
    Kiani A; Kuithan H; Kuithan F; Kyttälä S; Habermann I; Temme A; Bornhäuser M; Ehninger G
    Exp Hematol; 2007 May; 35(5):757-70. PubMed ID: 17577925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
    Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
    Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T; Zeier M; Schemmer P; Uhl W; Schoels M; Dengler T; Buechler M; Meuer S
    Transplantation; 2004 Feb; 77(3):339-44. PubMed ID: 14966405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
    Takeda A; Goolsby C; Yaseen NR
    Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.